NIH-funded research R01 grant

Using a Bionic Pancreas to Manage Diabetes During Pregnancy

Official title: Clinical Studies Investigating Use of the Bionic Pancreas in Pregnancy

Funded at Massachusetts General Hospital · NIH-10975177 · Data updated 2026-11-12

This study is looking at how the iLet Bionic Pancreas can help pregnant people with type 1 and type 2 diabetes manage their blood sugar better, making their pregnancy safer and healthier.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 10, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$725,628
NIH project number1R01DK140780-01
Project IDNIH-10975177 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant individuals diagnosed with type 1 or type 2 diabetes who are seeking improved management of their blood glucose levels.

Less likely to help

Patients without diabetes or those who are not pregnant may not receive any benefit from this research.

What this research studies

This research investigates the use of the iLet Bionic Pancreas, an automated insulin delivery system, to improve blood sugar control in pregnant individuals with type 1 and type 2 diabetes. The study aims to address the challenges of maintaining safe blood glucose levels during pregnancy, which can be particularly difficult due to hormonal changes and the risk of hypoglycemia. By including pregnant individuals in clinical trials, the research seeks to evaluate how this technology can enhance glycemic management and reduce complications associated with diabetes in pregnancy.

Why it matters

Potential benefit: If successful, this research could significantly improve pregnancy outcomes for individuals with diabetes by providing better blood sugar control and reducing the risk of complications.

How similar studies have gone: Previous studies have shown promising results with automated insulin delivery systems in non-pregnant populations, but this research is novel in its focus on pregnant individuals.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Powe, Camille Elise — Massachusetts General Hospital
  • Study coordinator: Powe, Camille Elise

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.